Herbalife Ltd HLF

12.55 0.34 2.78% as of 25 Sep
Market cap
$1.3B
P/E
7.8×
Growth Flags show if company had growth for consecutive years,
Insider Buys alert about insiders buying in the last 12 month

Insider Decisions

Total buys 0.18
Total sells 2.55
in millions of $
Nov 25 Feb 26 May 26 Aug 26
Buy — 2 — — — — — — 1 — — —
Sell — — — — — — — 2 — — — —
Insider Ownership 2.59%

Capital & Financial Ratios

Market Cap 1,280.00
Revenue 5,200.70
Net Income 162.90
Free Cash Flow 322.30
Net Debt 1,645.20
Current Ratio 1.20
Debt/Equity (4.32)
P/E ratio 7.84
P/S ratio 0.25
P/B ratio 0.00
Past 5Y EPS Growth 2.65%
This Y EPS Growth 15.10%
Next Y EPS Growth 24.97%
Next 5Y EPS Growth 18.73%
in millions of $

Dividends

Payout Ratio 0.00
Annual Dividend Rate —
Annual Dividend Yield —
total individual payouts
2025 Powerpack
2024 Powerpack
2023 Powerpack
2022 Powerpack
2021 Powerpack
2020 Powerpack
2019 Powerpack
2017 Powerpack
predictions in italic, special payouts not included in total or ratios

Assets vs Liabilities

2023 2024 2025 Q'26
Cash 575 415 353 371
Receivables 81 69 92 116
Inventory 505 475 512 508
Other — — — —
1,399 1,144 1,145 1,169
2023 2024 2025 Q'26
Payables 84 70 100 101
ST’ Debt 310 284 21 12
Other 884 517 490 482
1,278 1,230 1,013 974
in millions of $

Compound Annual Growth

10y 5y 3y
Sales 1.20% (1.89%) (1.08%)
Cash Flow (6.15%) (11.92%) (1.85%)
Earnings (3.88%) (9.33%) (10.77%)
Book Value 0.00% 0.00% 0.00%

Revenue

Mar Jun Sep Dec Year
’26 1,317 1,327 — — —
’25 1,222 1,259 1,274 1,283 5,038
’24 1,264 1,281 1,240 1,207 4,993
’23 1,252 1,314 1,281 1,215 5,062
’22 1,336 1,393 1,295 1,181 5,204
’21 1,502 1,552 1,431 1,318 5,803
’20 1,262 1,347 1,522 1,411 5,542
in millions of $ · fiscal quarters ending in the months shown

Operating Cash Flow

Mar Jun Sep Dec Year
’26 114 33 — — —
’25 0 96 139 98 333
’24 14 103 100 70 285
’23 46 136 80 96 358
’22 131 99 70 54 353
’21 110 177 88 85 460
’20 142 243 131 113 629
in millions of $ · fiscal quarters ending in the months shown

Free Cash Flow

Mar Jun Sep Dec Year
’26 103 22 — — —
’25 (18) 73 118 80 253
’24 (19) 66 72 44 163
’23 16 97 49 61 223
’22 89 64 32 11 196
’21 77 142 52 39 309
’20 117 218 105 76 517
in millions of $ · fiscal quarters ending in the months shown

EPS

Mar Jun Sep Dec Year
’26 0.57 (0.25) — — —
’25 0.49 0.48 0.42 0.81 2.20
’24 0.24 0.05 0.46 1.74 2.50
’23 0.29 0.60 0.43 0.10 1.42
’22 0.96 0.88 0.83 0.55 3.23
’21 1.33 1.31 1.09 0.37 4.13
’20 0.32 0.82 1.04 0.59 2.77
fiscal quarters ending in the months shown

Target Price Range

Analyst price targets

Recommendation Rating

1.6
1Buy 2 3Hold 4 5Sell
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028
21.13 24.10 33.76 33.62 20.73 36.52 12.04 11.14 6.21 5.04

Analyst estimates 2026–2028

Powerpack
Low Price
36.11 39.82 60.41 61.77 52.89 59.00 45.80 21.33 15.43 15.17
High Price
8,300 8,300 8,900 9,500 9,900 10,800 10,100 9,200 8,600 8,500
Employees
1 1 1 1 1 1 1 1 1 1
Revenue/Emp
4,488 4,428 4,892 4,877 5,542 5,803 5,204 5,062 4,993 5,038
Revenue
80.96% 80.83% 81.21% 80.36% 79.24% 78.64% 77.45% 76.47% 77.88% 77.87%
Gross Margin
365 471 464 451 516 561 425 203 169 275
EBT
8.13% 10.64% 9.49% 9.26% 9.32% 9.66% 8.16% 4.01% 3.39% 5.46%
EBT Margin
260 214 297 311 373 447 321 142 254 228
Net Income
98 100 100 98 100 108 115 113 121 121
Depreciation
27.02 27.94 34.89 35.50 42.14 54.80 52.84 51.14 49.63 49.00
Revenue/Sh
1.57 1.35 2.12 2.26 2.83 4.22 3.26 1.44 2.53 2.22
Earnings/Sh
2.21 3.73 4.62 3.33 4.78 4.35 3.58 3.61 2.84 3.24
Cash Flow/Sh
(0.86) (0.60) (0.60) (0.77) (0.85) (1.43) (1.59) (1.36) (1.21) (0.78)
Capex/Sh
1.35 3.12 4.03 2.56 3.93 2.92 1.99 2.25 1.62 2.46
Free CF/Sh
1.18 (2.11) (5.16) (2.84) (6.51) (13.14) (12.85) (10.71) (7.96) (4.96)
Book Value/Sh
166 159 140 137 132 106 99 99 101 103
Shares
15.72 27.21 28.00 21.09 16.92 9.79 4.59 10.74 2.65 5.78
PE Ratio
0.91 1.24 1.69 1.34 1.14 0.75 0.28 0.30 0.13 0.26
PS Ratio
20.82 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PB Ratio
1.04 1.46 1.95 1.54 1.39 1.12 0.70 0.69 0.50 0.59
EV/Sales
20.95 13.06 16.87 21.38 14.91 21.03 18.63 15.77 15.41 11.72
EV/FCF
367 591 648 458 629 460 353 358 285 333
Op' Cash Flow
(143) (95) (84) (106) (112) (151) (156) (135) (122) (80)
Capex
224 495 564 351 517 309 196 223 163 253
FCF
671 954 216 524 649 351 380 122 (87) 132
Working Cap'
1,448 2,268 2,454 1,803 2,428 2,763 2,692 2,562 2,260 1,993
Total Debt
604 989 1,255 964 1,383 2,161 2,184 1,987 1,845 1,640
Net Debt
196 (335) (723) (390) (856) (1,391) (1,266) (1,060) (801) (509)
Sh' Equity
10.31% 7.83% 10.43% 11.37% 12.95% 15.17% 11.57% 5.13% 9.18% 8.28%
ROA
35.78% 58.92% 80.33% 61.90% 75.99% 59.62% 37.11% 24.03% 23.11% 26.60%
ROIC
364.15% (309.10%) (56.06%) (55.86%) (59.80%) (39.79%) (24.18%) (12.23%) (27.32%) (34.84%)
ROE
predictions in italic, sparklines do not include predictions

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026

Herbalife Ltd (HLF) key facts

  • Herbalife Ltd (HLF) is a Packaged Foods company in the Consumer Defensive sector, listed on the New York Stock Exchange.
  • Herbalife Ltd’s revenue for fiscal 2025 (year ended December 2025) was $5.0 billion, up 0.89% from fiscal 2024.
  • Net income was $227.8 million, or $2.22 per share (basic), a net margin of 4.53%.
  • As of September 25, 2026, HLF traded at $12.55, a market capitalization of $1.3 billion.
  • At that price the stock trades at 7.8× trailing-twelve-month earnings and 0.3× sales.
  • Return on equity was −34.8% and debt-to-equity -4.32.

Source: company filings (standardised) and stockrow calculations.

Herbalife Ltd (HLF) Latest News

News by impact score

Fine-tune

23 Sep

3

Herbalife (HLF) board approves a share repurchase of up to $250 million over three years to buy back stock when value appears. Shares posted modest near-term momentum (about +2.6% in 1 day, +2.5% in 7 days) but remain down ~4.6% year-to-date; total return over the past year was 35.3%. The stock trades around $12.23 versus a fair value near $17, implying roughly 28% undervaluation per a consensus view. Risks include flat to declining volumes in several regions, reliance on distributor recruitment, and currency headwinds, suggesting top-line growth could stay pressured as markets mature. A push into personalized wellness technology could sharpen the investment thesis if distributor engagement holds, otherwise the buyback may reflect sentiment more than fundamentals. Buyback plus wellness push could modestly lift sentiment and valuation but core growth remains challenged by mature markets and macro headwinds.

15 Sep

3

Herbalife Ltd commits $250 million to repurchase its own shares amid recent stock price declines. Stock buyback of $250 million signals management confidence and may lift near-term investor sentiment.

8 Sep

3

Herbalife Ltd announces a $250 million share repurchase program. A $250 million share repurchase provides moderate support to stock price via increased demand and positive signaling to investors.

31 Aug

3

Herbalife (HLF) shares are declining sharply on negative developments pressuring the stock. Stock decline points to short-term pressure on market performance without clear long-term structural shifts.

3

Herbalife Ltd (HLF) announces planned CEO transition. Planned CEO transition may moderately shift strategy and investor views without altering core operations.

26 Aug

3

Herbalife outlines growth strategy centered on APAC momentum, margin expansion and debt reduction. Plans for APAC momentum, margin growth and debt cuts point to moderate influence on financial performance and market position.

20 Aug

3

Herbalife Ltd (HLF) is identified as the Russell 2000 stock with competitive advantages while two others receive negative recommendations. Positive mention of competitive advantages for Herbalife Ltd may shift investor sentiment and near-term share performance.

8 Aug

3 transcript

Herbalife Ltd (HLF) released Q2 earnings call highlights covering financial results, guidance, and operational updates. Q2 earnings and guidance typically affect near-term stock movement and sentiment but rarely shift long-term trajectory.

6 Aug

3

Herbalife Ltd shares fell 7.5% after reporting a profit swing and naming a new CFO in Q2 2026 results. Profit swing and CFO change point to operational and leadership issues that may pressure near-term performance and sentiment.

3 transcript

Herbalife Ltd posted fourth consecutive quarter of net sales growth in Q2 2026 earnings call. Four straight quarters of net sales growth point to sustained revenue gains that can lift Herbalife's valuation and sentiment.

5 Aug

3

Herbalife Ltd (HLF) exceeded Q2 CY2026 sales expectations. Quarterly sales beat provides moderate positive signal for near-term stock reaction without altering long-term company trajectory.

25 Jun

3

Herbalife Ltd and IIT Madras launch India's first Centre of Excellence on Plant Cell Fermentation Technology. India research center launch supports potential product innovation in nutrition sector.

29 May

3

Herbalife Ltd reported Q1 earnings placed in context of other personal care stocks' performance. Q1 earnings disclosure offers moderate insight into Herbalife operations versus sector peers.

22 May

3

Herbalife Ltd. beat first-quarter EPS estimates. Q1 EPS beat can lift near-term investor sentiment and stock price for Herbalife.

16 May

3

Herbalife's Q1 earnings call featured analyst questions focused on company growth strategies, regulatory matters, and operational outlook. Analyst questions in earnings calls provide insights into performance and strategy that moderately shape near-term market sentiment.

14 May

3

Herbalife's earnings quality reassures investors, as cash flow from operations significantly exceeds net earnings with a low accrual ratio of 7%, indicating reliable profitability backed by actual cash generation. Strong earnings quality highlights sustainable financial health, moderately boosting investor confidence and stock sentiment.

13 May

4

Herbalife Ltd (HLF) shares dropped 16.2% despite beating Q1 earnings expectations, refinancing debt, and announcing a strategic pivot toward personalized nutrition. Q1 earnings beat, debt refinancing, and pivot to personalized nutrition mark significant financial stabilization and strategic redirection amid sharp stock decline.

3

Herbalife partners with Cristiano Ronaldo to launch the 'Fuel Like Ronaldo' campaign, promoting performance nutrition products for integration into everyday routines. Cristiano Ronaldo endorsement boosts Herbalife's brand visibility and targets consumer engagement in nutrition, with moderate potential for sales uplift.

10 May

4

Herbalife released Q1 earnings call highlights, covering financial results, sales performance across regions, profitability metrics, cost management initiatives, and outlook for the year. Q1 earnings highlights reveal financial health, guidance, and strategies that significantly shape investor expectations and stock trajectory.

8 May

3

Herbalife partners with Cristiano Ronaldo to launch the 'Fuel Like Ronaldo' campaign, integrating performance nutrition products into everyday routines to inspire fans worldwide. Celebrity endorsement by Ronaldo boosts brand visibility and marketing reach, potentially lifting sales and investor sentiment moderately.

7 May

3

Herbalife Nutrition Ltd. released Q1 2026 earnings call summary detailing financial results, regional performance, and strategic initiatives. Earnings call summary reveals quarterly financials and outlook with moderately noticeable influence on performance and sentiment.

6 May

4 transcript

Herbalife Ltd (HLF) released Q1 2026 earnings call transcript covering financial results, revenue by region, net sales changes, adjusted EBITDA, management updates on strategy, distributor growth, and forward guidance. Q1 2026 earnings transcript discloses critical financial metrics, regional performance, and strategic guidance that significantly shape HLF's future trajectory and investor sentiment.

30 Apr

4

Pershing Square shares rebounded after Bill Ackman bought Herbalife Ltd (HLF) stock. Ackman's purchase of HLF stock reverses his prior massive short position and could significantly lift investor sentiment and HLF's market performance.

29 Apr

4

Herbalife Ltd. completed a $1.45 billion senior secured refinancing, extending debt maturities and lowering interest costs to strengthen its balance sheet. The $1.45 billion refinancing extends maturities and reduces interest expenses, significantly bolstering Herbalife's financial stability and market perception.

20 Apr

3

Herbalife Ltd (HLF) issued $800 million in senior notes, prompting a detailed valuation review amid concerns over debt levels and financial health. $800 million senior notes offering impacts Herbalife's balance sheet and leverage, influencing financial performance moderately.

16 Apr

4

Herbalife India and IIT Madras signed a landmark agreement to establish India's first Centre of Excellence on Plant Cell Fermentation, advancing research and innovation in plant-based nutrition technologies. Strategic partnership with IIT Madras for India's first Plant Cell Fermentation CoE boosts Herbalife's R&D innovation and market positioning in the high-growth Indian nutrition sector.

15 Apr

4

Herbalife Ltd priced an $800 million aggregate principal amount senior secured notes offering. Pricing $800 million in senior secured notes represents a major financing move that bolsters liquidity and impacts debt structure and investor perception.

14 Apr

4

Herbalife Ltd. announced a proposed offering of $800 million aggregate principal amount of senior secured notes. Proposed $800 million senior secured notes offering constitutes a major financial maneuver altering debt profile and investor sentiment.

4

Herbalife reported preliminary Q1 2026 results with net sales above guidance and adjusted EBITDA expected at or above the high end of guidance, alongside an update on senior secured debt refinancing plans. Preliminary results beating sales guidance, strong EBITDA outlook, and debt refinancing update signal significant positive shifts in financial health and market perception.

9 Apr

4

Herbalife Ltd (HLF) agrees to acquire Bioniq assets to expand into personalized nutrition. Acquisition of Bioniq assets represents a major strategic move to bolster Herbalife's personalized nutrition capabilities and competitive edge.

stockrow.com/HLF · Data as of Jun 30, 2026 · For information only; not investment advice. · © 2026 stockrow.com